Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Relief Therapeutics Holding AG is a Switzerland based drug development company focusing on clinical stage projects, primarily developing drugs of natural human origin. It is engaged in its operations for diabetic complications and respiratory diseases. The company is focused on developing drug candidates namely, Aviptadil and Atexakin alfa. Aviptadil is a biologically active endogenous human peptide that possesses anti-proliferative, anti-inflammatory, and immune regulatory activities. Atexakin alfa is a low dosage formulation of interleukin-6 that exhibits functions in diverse tissues and organs. The group operates its functions in Switzerland.
| Last: | $1.41 |
|---|---|
| Change Percent: | -20.72% |
| Open: | $1.41 |
| Close: | $1.41 |
| High: | $1.41 |
| Low: | $1.41 |
| Volume: | 237 |
| Last Trade Date Time: | 01/26/2026 10:17:11 am |
| Market Cap: | $17,857,805 |
|---|---|
| Float: | 21,964,203 |
| Insiders Ownership: | N/A |
| Institutions: | 35 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://mindmazetherapeutics.com |
| Country: | CH |
| City: | Geneva |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Relief Therapeutics Holding SA (OTCMKTS: RLFTY).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
